EVERPAR ADVISORS LLC

Position in MRK — Merck & Co., Inc.

CIK 2010410 TULSA, OK

Position in MRK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,210,084

+$62,518 QoQ

Shares Held

9,417

-1.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#1,962

of 3,769 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

EVERPAR ADVISORS LLC holds $12,411,314 across 10 Drug Manufacturers - General names. MRK ranks #4 (9.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,780	$3,334,415
2	JNJ	Johnson & Johnson	12,152	$3,086,243
3	ABBV	AbbVie Inc.	6,863	$1,727,005
4	MRK	Merck & Co., Inc. This page	9,417	$1,210,084
5	AMGN	Amgen Inc	2,218	$803,182
6	GILD	Gilead Sciences, Inc.	4,488	$567,013
7	AZN	Astrazeneca PLC	2,894	$548,760
8	BMY	Bristol Myers Squibb Co	8,874	$511,319

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,210,084	9,417	-1.3%	Shares	Sole	2026-07-09
2026-03-31	$1,147,566	9,540	+16.0%	Shares	Sole	2026-04-21
2025-12-31	$865,974	8,227	-17.1%	Shares	Sole	2026-01-07
2025-09-30	$832,921	9,924	-3.1%	Shares	Sole	2025-10-17
2025-06-30	$810,519	10,239	-7.4%	Shares	Sole	2025-07-08
2025-03-31	$992,925	11,062	-18.7%	Shares	Sole	2025-04-16
2024-12-31	$1,353,325	13,604	-3.2%	Shares	Sole	2025-01-15
2024-09-30	$1,595,290	14,048	-9.6%	Shares	Sole	2024-10-07
2024-06-30	$1,924,718	15,547	+11.0%	Shares	Sole	2024-07-18
2024-03-31	$1,848,619	14,010	-29.0%	Shares	Sole	2024-04-22
2023-12-31	$2,151,073	19,731	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.